Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia

Bi Fang Lee, Lan Wan Wang, Sheng Hsiang Lin, Ting Jyun Jhuo, Nan Tsing Chiu, Chao Ching Huang, Chien Chung Hsia, Lie Hang Shen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: Hypoxic-ischemic insult in newborns results in progressive neuronal loss. For neuroprotective therapy to be effective, it is important to identify high-risk neonates soon after birth. Tc-labeled imaging agent, Tc-99m-HL91, developed as a putative hypoxic reagent, has been reported to demonstrate increased uptake in ischemic myocardium. We hypothesized that Tc-99m-HL91 is sensitive for the early identification of hypoxic-ischemic injury in neonatal rat brains. Design: Laboratory investigation. Setting: University research laboratory. Subjects: Sprague-Dawley rat pups. Interventions: Postnatal day-7 pups were divided into four groups: hypoxic-ischemia, hypoxia-only, ischemia-only, and controls. In the early (2 hrs), intermediate (20 hrs), and late (44 hrs) reoxygenation phases, Tc-99m-HL91 in vivo and ex vivo imaging and quantitative autoradiography were performed. Regions of interest were drawn to calculate the contrast ratio of Tc-99m-HL91 uptake between the ipsilateral and contralateral hemispheres. Pathology, cerebral blood flow, and blood-brain barrier damage were determined. Measurements and Main Results: After hypoxic-ischemia, there were very few pyknotic neurons in the early phase, many pyknotic neurons in the intermediate phase, and extensive neuronal loss in the late phase postreoxygenation. Blood-brain barrier damage occurred in the early phase, progressed in the intermediate phase, and became extensive in the late phase. The hypoxia-only and ischemia-only pups showed no neuronal or blood-brain barrier damage and had higher cerebral blood flow postreoxygenation compared with the hypoxia-ischemia pups. Regions of interest analysis of in vivo and ex vivo images and autoradiography revealed significantly higher Tc-99m-HL91 contrast ratio at early and intermediate phases, not late phase of hypoxic-ischemic group. Hypoxic-ischemia group had significantly higher contrast ratio values in the early and intermediate phases than the hypoxia-only and ischemia-only groups. A contrast ratio value of 0.15 in the early phase on postnatal day 7 had a sensitivity of 0.95 and specificity of 0.89 in detecting significant hypoxic-ischemic lesions on postnatal day 21. Conclusion: Tc-99m-HL91 uptake is sensitive for the early detection of hypoxic-ischemic injury in neonatal brains.

Original languageEnglish
Pages (from-to)1930-1938
Number of pages9
JournalCritical Care Medicine
Volume40
Issue number6
DOIs
Publication statusPublished - Jun 2012
Externally publishedYes

Fingerprint

Ischemia
Wounds and Injuries
Cerebrovascular Circulation
Blood-Brain Barrier
Autoradiography
Neurons
Brain
Sprague Dawley Rats
Myocardium
Parturition
Pathology
Sensitivity and Specificity
Hypoxia
Research

Keywords

  • blood-brain barrier
  • cerebral blood flow
  • hypoxic-ischemia
  • neonatal brain
  • neuroimaging
  • Tc-99m-HL91

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia. / Lee, Bi Fang; Wang, Lan Wan; Lin, Sheng Hsiang; Jhuo, Ting Jyun; Chiu, Nan Tsing; Huang, Chao Ching; Hsia, Chien Chung; Shen, Lie Hang.

In: Critical Care Medicine, Vol. 40, No. 6, 06.2012, p. 1930-1938.

Research output: Contribution to journalArticle

Lee, Bi Fang ; Wang, Lan Wan ; Lin, Sheng Hsiang ; Jhuo, Ting Jyun ; Chiu, Nan Tsing ; Huang, Chao Ching ; Hsia, Chien Chung ; Shen, Lie Hang. / Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia. In: Critical Care Medicine. 2012 ; Vol. 40, No. 6. pp. 1930-1938.
@article{a6bd06ede8794da4bbacf00f2115454f,
title = "Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia",
abstract = "Objective: Hypoxic-ischemic insult in newborns results in progressive neuronal loss. For neuroprotective therapy to be effective, it is important to identify high-risk neonates soon after birth. Tc-labeled imaging agent, Tc-99m-HL91, developed as a putative hypoxic reagent, has been reported to demonstrate increased uptake in ischemic myocardium. We hypothesized that Tc-99m-HL91 is sensitive for the early identification of hypoxic-ischemic injury in neonatal rat brains. Design: Laboratory investigation. Setting: University research laboratory. Subjects: Sprague-Dawley rat pups. Interventions: Postnatal day-7 pups were divided into four groups: hypoxic-ischemia, hypoxia-only, ischemia-only, and controls. In the early (2 hrs), intermediate (20 hrs), and late (44 hrs) reoxygenation phases, Tc-99m-HL91 in vivo and ex vivo imaging and quantitative autoradiography were performed. Regions of interest were drawn to calculate the contrast ratio of Tc-99m-HL91 uptake between the ipsilateral and contralateral hemispheres. Pathology, cerebral blood flow, and blood-brain barrier damage were determined. Measurements and Main Results: After hypoxic-ischemia, there were very few pyknotic neurons in the early phase, many pyknotic neurons in the intermediate phase, and extensive neuronal loss in the late phase postreoxygenation. Blood-brain barrier damage occurred in the early phase, progressed in the intermediate phase, and became extensive in the late phase. The hypoxia-only and ischemia-only pups showed no neuronal or blood-brain barrier damage and had higher cerebral blood flow postreoxygenation compared with the hypoxia-ischemia pups. Regions of interest analysis of in vivo and ex vivo images and autoradiography revealed significantly higher Tc-99m-HL91 contrast ratio at early and intermediate phases, not late phase of hypoxic-ischemic group. Hypoxic-ischemia group had significantly higher contrast ratio values in the early and intermediate phases than the hypoxia-only and ischemia-only groups. A contrast ratio value of 0.15 in the early phase on postnatal day 7 had a sensitivity of 0.95 and specificity of 0.89 in detecting significant hypoxic-ischemic lesions on postnatal day 21. Conclusion: Tc-99m-HL91 uptake is sensitive for the early detection of hypoxic-ischemic injury in neonatal brains.",
keywords = "blood-brain barrier, cerebral blood flow, hypoxic-ischemia, neonatal brain, neuroimaging, Tc-99m-HL91",
author = "Lee, {Bi Fang} and Wang, {Lan Wan} and Lin, {Sheng Hsiang} and Jhuo, {Ting Jyun} and Chiu, {Nan Tsing} and Huang, {Chao Ching} and Hsia, {Chien Chung} and Shen, {Lie Hang}",
year = "2012",
month = "6",
doi = "10.1097/CCM.0b013e31824e1883",
language = "English",
volume = "40",
pages = "1930--1938",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Tc-99m-HL91 imaging in the early detection of neuronal injury in a neonatal rat model of hypoxic ischemia

AU - Lee, Bi Fang

AU - Wang, Lan Wan

AU - Lin, Sheng Hsiang

AU - Jhuo, Ting Jyun

AU - Chiu, Nan Tsing

AU - Huang, Chao Ching

AU - Hsia, Chien Chung

AU - Shen, Lie Hang

PY - 2012/6

Y1 - 2012/6

N2 - Objective: Hypoxic-ischemic insult in newborns results in progressive neuronal loss. For neuroprotective therapy to be effective, it is important to identify high-risk neonates soon after birth. Tc-labeled imaging agent, Tc-99m-HL91, developed as a putative hypoxic reagent, has been reported to demonstrate increased uptake in ischemic myocardium. We hypothesized that Tc-99m-HL91 is sensitive for the early identification of hypoxic-ischemic injury in neonatal rat brains. Design: Laboratory investigation. Setting: University research laboratory. Subjects: Sprague-Dawley rat pups. Interventions: Postnatal day-7 pups were divided into four groups: hypoxic-ischemia, hypoxia-only, ischemia-only, and controls. In the early (2 hrs), intermediate (20 hrs), and late (44 hrs) reoxygenation phases, Tc-99m-HL91 in vivo and ex vivo imaging and quantitative autoradiography were performed. Regions of interest were drawn to calculate the contrast ratio of Tc-99m-HL91 uptake between the ipsilateral and contralateral hemispheres. Pathology, cerebral blood flow, and blood-brain barrier damage were determined. Measurements and Main Results: After hypoxic-ischemia, there were very few pyknotic neurons in the early phase, many pyknotic neurons in the intermediate phase, and extensive neuronal loss in the late phase postreoxygenation. Blood-brain barrier damage occurred in the early phase, progressed in the intermediate phase, and became extensive in the late phase. The hypoxia-only and ischemia-only pups showed no neuronal or blood-brain barrier damage and had higher cerebral blood flow postreoxygenation compared with the hypoxia-ischemia pups. Regions of interest analysis of in vivo and ex vivo images and autoradiography revealed significantly higher Tc-99m-HL91 contrast ratio at early and intermediate phases, not late phase of hypoxic-ischemic group. Hypoxic-ischemia group had significantly higher contrast ratio values in the early and intermediate phases than the hypoxia-only and ischemia-only groups. A contrast ratio value of 0.15 in the early phase on postnatal day 7 had a sensitivity of 0.95 and specificity of 0.89 in detecting significant hypoxic-ischemic lesions on postnatal day 21. Conclusion: Tc-99m-HL91 uptake is sensitive for the early detection of hypoxic-ischemic injury in neonatal brains.

AB - Objective: Hypoxic-ischemic insult in newborns results in progressive neuronal loss. For neuroprotective therapy to be effective, it is important to identify high-risk neonates soon after birth. Tc-labeled imaging agent, Tc-99m-HL91, developed as a putative hypoxic reagent, has been reported to demonstrate increased uptake in ischemic myocardium. We hypothesized that Tc-99m-HL91 is sensitive for the early identification of hypoxic-ischemic injury in neonatal rat brains. Design: Laboratory investigation. Setting: University research laboratory. Subjects: Sprague-Dawley rat pups. Interventions: Postnatal day-7 pups were divided into four groups: hypoxic-ischemia, hypoxia-only, ischemia-only, and controls. In the early (2 hrs), intermediate (20 hrs), and late (44 hrs) reoxygenation phases, Tc-99m-HL91 in vivo and ex vivo imaging and quantitative autoradiography were performed. Regions of interest were drawn to calculate the contrast ratio of Tc-99m-HL91 uptake between the ipsilateral and contralateral hemispheres. Pathology, cerebral blood flow, and blood-brain barrier damage were determined. Measurements and Main Results: After hypoxic-ischemia, there were very few pyknotic neurons in the early phase, many pyknotic neurons in the intermediate phase, and extensive neuronal loss in the late phase postreoxygenation. Blood-brain barrier damage occurred in the early phase, progressed in the intermediate phase, and became extensive in the late phase. The hypoxia-only and ischemia-only pups showed no neuronal or blood-brain barrier damage and had higher cerebral blood flow postreoxygenation compared with the hypoxia-ischemia pups. Regions of interest analysis of in vivo and ex vivo images and autoradiography revealed significantly higher Tc-99m-HL91 contrast ratio at early and intermediate phases, not late phase of hypoxic-ischemic group. Hypoxic-ischemia group had significantly higher contrast ratio values in the early and intermediate phases than the hypoxia-only and ischemia-only groups. A contrast ratio value of 0.15 in the early phase on postnatal day 7 had a sensitivity of 0.95 and specificity of 0.89 in detecting significant hypoxic-ischemic lesions on postnatal day 21. Conclusion: Tc-99m-HL91 uptake is sensitive for the early detection of hypoxic-ischemic injury in neonatal brains.

KW - blood-brain barrier

KW - cerebral blood flow

KW - hypoxic-ischemia

KW - neonatal brain

KW - neuroimaging

KW - Tc-99m-HL91

UR - http://www.scopus.com/inward/record.url?scp=84861492373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861492373&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e31824e1883

DO - 10.1097/CCM.0b013e31824e1883

M3 - Article

C2 - 22610194

AN - SCOPUS:84861492373

VL - 40

SP - 1930

EP - 1938

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 6

ER -